Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 26, 2025PLoS ONEOpen Access

Combining transcriptomics with network pharmacology to explore the mechanism of Yiqi Huoxue decoction against liver fibrosis

View Full Paper
Ask AI
Bookmark
Share

Authors

KZKe ZhangDZDandan ZhaoJCJia-Wei Cui

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/694033d22d562116f2907a3ahttps://doi.org/10.1371/journal.pone.0337061
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking2024 · 1 citations
  2. 2Transcriptomic analysis reveals pharmacological mechanisms mediating efficacy of Yangyinghuoxue Decoction in CCl4-induced hepatic fibrosis in rats2024 · 2 citations
  3. 3Chinese herbal decoction, Yi-Qi-Jian-Pi formula exerts anti-hepatic fibrosis effects in mouse models of CCl4-induced liver fibrosis2024 · 7 citations
  4. 4Network pharmacology exploration reveals the bioactive compounds and molecular mechanisms by which Gui-Qi-Yang-Xin Decoction suppresses myocardial fibrosis2022
  5. 5IDDF2024-ABS-0308 YQHX inhibits hepatic stellate cells activation by suppressing NCOA4-mediated ferritinophagy in biliary atresia2024